AwardTape · Defense awards · Research and development · Health R&D · W81XWH22C0127
W81XWH22C0127: $4.1M definitive contract to Mantel Technologies, Inc
Mantel Technologies, Inc holds a definitive contract from Defense Health Agency with $4.1M obligated since Oct 2023 and $8.8M obligated over its life, against a ceiling of $8.8M. Latest action Feb 4, 2026.
Phase iii sbir research and development contract for project titled "canine freeze dried plasma system"
| PIID | W81XWH22C0127 |
|---|---|
| Type | definitive contract |
| Company | Mantel Technologies, Inc |
| Agency | Defense Health Agency |
| Contracting office | DEFENSE HEALTH AGENCY |
| Category | Research and development · Health R&D |
| PSC | AN13 HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT |
| NAICS | 541715 RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) |
| Obligated since Oct 2023 | $4.1M |
| Total obligated (lifetime) | $8.8M |
| Ceiling (base and all options) | $8.8M |
| Base date | Sep 16, 2022 |
| Latest action | Feb 4, 2026 |
| End date | Sep 30, 2026 |
| Actions since Oct 2023 | 4 |
| Pricing | Cost plus fixed fee |
| Competition | Competed after exclusion of sources |
| Place of performance | WA |
| Source | USAspending.gov record |
| Reporting lag | DoD 90 days |
Source: USAspending.gov prime award data (FPDS), DoD and DHS contracts, orders and IDVs with any action since Oct 1, 2023. Obligated FY2024+ sums the obligations on those actions; total obligated is the award's lifetime figure. DoD contract actions publish on USAspending about 90 days after signing (DFARS PGI 204.6), so the latest DoD actions here trail the calendar by about 3 months. Place of performance shows the state only.
Terminal: alerts on new orders and modifications to this contract, and CSV export.
7 days free for first-time subscribers, then $49/mo. Card required. Cancel before day 8 and you pay nothing.
Start free trial